An interventional study of Extracorporeal Shock Wave Therapy (ESWT) and Shock Wave Therapy with Traditional Physical Therapy in Chronic Supraspinatus Tendinitis in Tennis Players, sponsored by Kafrelsheikh University. Not yet recruiting. Open to participants aged 16 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Study Goal: To compare the effect of shock wave therapy alone versus shock wave therapy combined with traditional physical therapy for tennis players suffering from chronic supraspinatus tendinitis.
Study Design: A pre-post randomized controlled experimental trial where participants are randomly assigned into two equal groups.
Participants: 70 tennis players of both genders (aged 16 to 65 years) with chronic supraspinatus tendinitis, divided into 35 participants per group.
Intervention \& Duration: The treatment period consists of 12 sessions spanning one and a half months.
Evaluation Metrics: Shoulder range of motion (measured via electronic goniometer), shoulder pain (measured via numeric anlage scale), and shoulder function (assessed via shoulder joint functional index).
397 studies on the registry are indexed under Tendinopathy; 77 are open to participants now.
This study's planned enrollment of 70 is above the median of 48 across 332 interventional studies indexed under Tendinopathy.
Browse Tendinopathy studies →Kafrelsheikh University is the lead sponsor of 300 studies on the registry; 119 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: Extracorporeal Shock Wave Therapy (ESWT)
Procedure: Shock Wave Therapy with Traditional Physical Therapy
Participants will receive 12 sessions of extracorporeal shock wave therapy (ESWT) alone, administered at a frequency of two sessions per week for a total duration of one and a half months.
Participants will receive 12 sessions of extracorporeal shock wave therapy combined with traditional physical therapy, administered at a frequency of two sessions per week for a total duration of one and a half months.
Shoulder pain (measured via numeric anlage scale)
Time frame: Pre-post evaluation conducted across a treatment period of one and a half months (totaling 12 sessions at a frequency of two sessions per week).
Shoulder range of motion (measured via electronic goniometer)
Time frame: Pre-post evaluation conducted across a treatment period of one and a half months (totaling 12 sessions at a frequency of two sessions per week).
Shoulder function (assessed by shoulder joint functional index)
Time frame: Pre-post evaluation conducted across a treatment period of one and a half months (totaling 12 sessions at a frequency of two sessions per week).
No study locations are listed for this record.
Plan to share: Undecided — Data will be shared upon reasonable request from the principal investigator.
Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.
Of 173 non-industry interventional studies with no phase under Tendinopathy, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 37. This study's planned 2 months is below that.
Counting every sponsor, half of 182 studies reached it within 20 months; a quarter within 7 and three quarters within 37.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.